Roche

News

Report warns of UK's rare disease 'postcode lottery'

There is still a ‘postcode lottery’ for patients getting access to vital rare disease treatments in the UK, according to a new report.

News

Mixed results from Roche's key new drugs in Q1

Lacklustre performance from GSK as results season begins

News

FDA rejects Pfizer Herceptin biosimilar, wants technical inf...

A Pfizer-produced biosimilar of Roche’s blockbuster breast cancer drug, Herceptin, has been rejected by US regulators.

News

AstraZeneca Amenities Building - Mississauga - Sept 2005
Non exclusive, unlimited time license for print & web to WZMH Architects

AZ's Tagrisso approved for untreated lung cancer in US

Tagrisso outperformed first-generation TKI drugs in FLAURA trial

News

VC digital health funding reached record $2.5bn in Q1

Roche's $1.9bn Flatiron Health buy was standout deal

News

Roche haemophilia drug gets fast FDA review in expanded use

The FDA has granted ‘Breakthrough Therapy’ status for Roche’s Hemlibra (emicizumab) for people with haemophilia A without factor VIII inhibitors, as the Swiss firm aims to take market share

Report warns of UK's rare disease 'postcode lottery'

Mixed results from Roche's key new drugs in Q1

FDA rejects Pfizer Herceptin biosimilar, wants technical inf...

AZ's Tagrisso approved for untreated lung cancer in US

VC digital health funding reached record $2.5bn in Q1

Roche haemophilia drug gets fast FDA review in expanded use

Grail cancer test gets lukewarm backing from FDA adcomm

Discover a new era of healthcare panel engagement: Grounded ...

Roche

Editor's Picks